C. Carter

S. Steinberg, B. Levine, C. June, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

In vivo distribution of adoptively transferred indium-111-labeled tumor infiltrating lymphocytes and peripheral blood lymphocytes in patients with metastatic melanoma.

S. Rosenberg, J. Carrasquillo, E. Read, 1989, Journal of the National Cancer Institute.

Granulocyte transfusion therapy in a child with chronic granulomatous disease and multiple red cell alloantibodies

S. Leitman, C. Carter, J. Gallin, 1989, Transfusion.

pan-differentiation of CD34pos cells into tumor-competent dendritic cells STAT3- and STAT5-dependent pathways competitively regulate the

B. Czerniecki, Xin-Yuan Fu, J. Tisdale, 2013 .

cells cells into tumor-competent dendritic pos pan-differentiation of CD34 STAT3- and STAT5-dependent pathways competitively regulate the

B. Czerniecki, Xin-Yuan Fu, J. Tisdale, 2011 .

STAT3- and STAT5-dependent pathways competitively regulate the pan-differentiation of CD34pos cells into tumor-competent dendritic cells.

B. Czerniecki, Xin-Yuan Fu, J. Tisdale, 2008, Blood.

Development of an automated closed system for generation of human lymphokine-activated killer (LAK) cells for use in adoptive immunotherapy.

S. Rosenberg, K. Nason-Burchenal, L. Muul, 1987, Journal of immunological methods.

Enumeration of CD34+ hematopoietic progenitor cells in peripheral blood and leukapheresis products by microvolume fluorimetry: a comparison with flow cytometry.

H. Klein, E. Read, C. Carter, 1997, Journal of hematotherapy.

Optimized clinical-scale culture conditions for ex vivo selective depletion of host-reactive donor lymphocytes: a strategy for GvHD prophylaxis in allogeneic PBSC transplantation.

J. Michálek, A. Barrett, V. Ghetie, 2002, Cytotherapy.

Enumeration of cells in bone marrow and peripheral blood stem cell collections: technical issues and prospects for standardization.

E. Read, C. Carter, 1992, Journal of hematotherapy.

Engraftment kinetics after nonmyeloablative allogeneic peripheral blood stem cell transplantation: full donor T-cell chimerism precedes alloimmune responses.

N. Young, A. Barrett, N. Hensel, 1999, Blood.

Retroviral transfer of the glucocerebrosidase gene into CD34+ cells from patients with Gaucher disease: in vivo detection of transduced cells without myeloablation.

R. Schiffmann, S. Karlsson, R. Brady, 1998, Human gene therapy.

Development of a clinical-scale method for generation of dendritic cells from PBMC for use in cancer immunotherapy.

J. Berzofsky, C. Mackall, E. Read, 2001, Cytotherapy.

Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia.

K. Rezvani, A. Barrett, R. Childs, 2006, Blood.

Extended-cycle elutriation to adjust T-cell content in HLA-disparate bone marrow transplantation.

G. Reaman, S. Karandish, R. Gress, 1993, Blood.

Stimulatory effect of counterflow centrifugal elutriation in large‐scale separation of peripheral blood monocytes can be reversed by storing the cells at 37°c

E. Read, P. Pizzo, C. Carter, 1991, Journal of clinical apheresis.

Peripheral blood mononuclear cell collection from patients undergoing adoptive immunotherapy or peripheral blood‐derived stem cell transplantation and from healthy donors

U. Keilholz, C. Carter, M. Körbling, 1991, Journal of clinical apheresis.

A simplified automated procedure for generation of human lymphokine-activated killer cells for use in clinical trials.

S. Rosenberg, P. Aebersold, S. Leitman, 1988, Journal of immunological methods.

Prospective evaluation of cell kinetics, yields and donor experiences during a single large‐volume apheresis versus two smaller volume consecutive day collections of allogeneic peripheral blood stem cells

A. Barrett, R. Childs, E. Read, 2003, British journal of haematology.

Pilot trial of tumor-specific peptide vaccination and continuous infusion interleukin-2 in patients with recurrent Ewing sarcoma and alveolar rhabdomyosarcoma: an inter-institute NIH study.

J. Berzofsky, L. Helman, C. Mackall, 2002, Medical and pediatric oncology.

After Breast Cancer Chemotherapy Engraftment of MDR1 and NeoR Gene-Transduced Hematopoietic Cells

I. Pastan, M. Gottesman, D. Venzon, 2013 .

Treatment of chronic granulomatous disease with nonmyeloablative conditioning and a T-cell-depleted hematopoietic allograft.

S. Holland, A. Barrett, R. Childs, 2001, The New England journal of medicine.

Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation.

A. Barrett, N. Hensel, V. Ghetie, 2005, Blood.

Viability of platelets following storage in the irradiated state. A pair‐controlled study

E. Read, S. Leitman, C. Carter, 1988, Transfusion.

Efficacy of various methods of confidential unit exclusion in identifying potentially infectious blood donations

G. R. Carter, S. Leitman, C. Carter, 1989, Transfusion.

Dendritic cells signal T cells in the absence of exogenous antigen

Roland Martin, I. Cortese, T. Kondo, 2001, Nature Immunology.

Comparison of automated culture systems with a CFR/USP-compliant method for sterility testing of cell-therapy products.

P. Murray, F. Stock, E. Read, 2004, Cytotherapy.

Immunization with mutant p53- and K-ras-derived peptides in cancer patients: immune response and clinical outcome.

J. Berzofsky, J. Minna, D. Carbone, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Allogeneic lymphocytes induce tumor regression of advanced metastatic breast cancer.

S. Steinberg, M. Bishop, J. Gea-Banacloche, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Catastrophic failures of freezing bags for cellular therapy products: description, cause, and consequences.

R. M. Childs, E. Read, C. Carter, 2002, Cytotherapy.

Preferential survival of CD4+ T lymphocytes engineered with anti-human immunodeficiency virus (HIV) genes in HIV-infected individuals.

H Clifford Lane, J. Metcalf, M. Baseler, 2005, Human gene therapy.

Peripheral expansion of pre-existing mature T cells is an important means of CD4+ T-cell regeneration HIV-infected adults

J. Metcalf, R. Davey, M. Baseler, 1998, Nature Medicine.

A study of the safety and survival of the adoptive transfer of genetically marked syngeneic lymphocytes in HIV-infected identical twins.

H. Lane, R. Blaese, S. Leitman, 1993, Human gene therapy.

CD34+ cell dose predicts survival, posttransplant morbidity, and rate of hematologic recovery after allogeneic marrow transplants for hematologic malignancies

C. Dunbar, D. Couriel, E. Read, 1996 .

Use of a continuous‐flow cell separator in density gradient isolation of lymphocytes

S. Rosenberg, K. Nason-Burchenal, L. Muul, 1987, Transfusion.

Bulk cryopreservation of lymphocytes in glycerol

E. Read, C. Carter, T. Simonis, 1988, Transfusion.

T-cell depleted peripheral blood stem cell allotransplantation with T-cell add-back for patients with hematological malignancies: effect of chronic GVHD on outcome.

K. Rezvani, A. Barrett, R. Childs, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells

J. Berzofsky, D. Douek, B. Hill, 2005, Nature Medicine.

Radiolabeled platelet survival studies

E. Read, C. Carter, 1986, Transfusion.

Technical aspects of lymphokine‐activated killer cell production

S. Rosenberg, K. Nason-Burchenal, L. Muul, 1988, Journal of clinical apheresis.

Development of a closed-system process for clinical-scale generation of DCs: evaluation of two monocyte-enrichment methods and two culture containers.

E. Read, W. Kopp, C. Carter, 2002, Cytotherapy.

Gene therapy-based treatment for HIV-positive patients with malignancies.

R. Morgan, A. Barrett, J. Tisdale, 2002, Journal of hematotherapy & stem cell research.

Human G‐CSF‐mobilized CD34‐positive peripheral blood progenitor cells can stimulate allogeneic T‐cell responses: implications for graft rejection in mismatched transplantation

N. Hensel, A. Raptis, R. Childs, 1999, British journal of haematology.

Prolonged CD4 depletion after sequential autologous peripheral blood progenitor cell infusions in children and young adults.

C. Mackall, E. Read, L. Wexler, 2000, Blood.

In vivo traffic of indium-111-oxine labeled human lymphocytes collected by automated apheresis.

E. Read, C. Carter, A. Keenan, 1990, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

Nonmyeloablative conditioning followed by transplantation of genetically modified HLA-matched peripheral blood progenitor cells for hematologic malignancies in patients with acquired immunodeficiency syndrome.

R. Morgan, A. Barrett, J. Tisdale, 2002, Blood.

malignancies in patients with acquired immunodeficiency syndrome modified HLA-matched peripheral blood progenitor cells for hematologic Nonmyeloablative conditioning followed by transplantation of genetically

R. Morgan, R. Childs, H. Malech, 2013 .

hematologic malignancies of hematologic recovery after allogeneic marrow transplants for CD34+ cell dose predicts survival, posttransplant morbidity, and rate

D. Couriel, M. Cottler-Fox, C. Carter, 2011 .

Optimization of parameters for maximization of plateletpheresis and lymphocytapheresis yields on the haemonetics model V50

J. AuBuchon, C. Carter, H. Klein, 1986, Journal of clinical apheresis.

Sterility testing of cell therapy products: parallel comparison of automated methods with a CFR‐compliant method

P. Murray, E. Read, C. Carter, 2006, Transfusion.

Helper T Cells Infiltrating Human Renal Cell Carcinomas Have the Phenotype of Activated Memory‐Like T Lymphocytes

S. Rosenberg, A. Mixon, R. Alexander, 1995, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Retroviral gene transduction of adult peripheral blood or marrow-derived CD34+ cells for six hours without growth factors or on autologous stroma does not improve marking efficiency assessed in vivo.

K. Cowan, J. O’Shaughnessy, J. Zujewski, 1997, Blood.

Use of interleukin-7, interleukin-2, and interferon-gamma to propagate CD4+ T cells in culture with maintained antigen specificity.

S. Rosenberg, J. Mulé, R. Alexander, 1993, Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy.

Epidermal cell production of thymocyte activating factor (ETAF).

C. Carter, J. Oppenheim, S. Katz, 1982, The Journal of investigative dermatology.